Nierenzentrum Freiburg

Freiburg im Breisgau 79100

1 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Inflammation, Kidney Disease, Chronic

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed